Zobrazeno 1 - 10
of 50
pro vyhledávání: '"S .D. Silberstein"'
Autor:
S D, Silberstein, D W, Dodick, A S, Lindblad, K, Holroyd, M, Harrington, N T, Mathew, D, Hirtz, Leigh Anne, Kreshel
Publikováno v:
Neurology. 78:976-984
Objective: To assess the efficacy and safety of adding propranolol to topiramate in chronic migraine subjects inadequately controlled with topiramate alone. Methods: This was a double-blind, placebo-controlled, randomized clinical trial conducted thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d514553aa28e136ae66e4bac5dd12064
https://doi.org/10.1212/wnl.0b013e31824d5846
https://doi.org/10.1212/wnl.0b013e31824d5846
Autor:
Peter J. Goadsby, H. Gobel, M. J. A. Lainez, R. B. Lipton, Jes Olesen, M. B. First, G. Nappi, H.-C. Diener, Jean Schoenen, T. Steiner, M.-G. Bousser, S. D. Silberstein, D. Dodick, F. Sakai
Publikováno v:
Cephalalgia. 29:1331-1336
Headache classification is a dynamic process through clinical testing and re-testing of current and proposed criteria. After publication of the second edition of the International Classification of Headache Disorders (ICHD-II), need arose for revisio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32057ffa1ef2af1d1ecfba9d027ca899
https://doi.org/10.1111/j.1468-2982.2009.01965.x
https://doi.org/10.1111/j.1468-2982.2009.01965.x
Autor:
D W, Dodick, S D, Silberstein
Publikováno v:
Practical Neurology. 7:383-393
Preventive medications reduce migraine frequency and severity, and improve migraine-specific quality of life. Recent evidence also suggests that these same medications enhance the patient's response to acute migraine therapies, and may also reduce th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25504e76bff4cd408dae28c5799ce9a5
https://doi.org/10.1136/jnnp.2007.134023
https://doi.org/10.1136/jnnp.2007.134023
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 70:613-617
OBJECTIVE—To study the clinical characteristics of cluster headache in women. Cluster headache is a disorder of men (male to female ratio 6-7:1). METHODS—Retrospective chart review to identify all women diagnosed with cluster headache at an acade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c568e64bb22c6d8f6a4cabfb73f8b28
https://doi.org/10.1136/jnnp.70.5.613
https://doi.org/10.1136/jnnp.70.5.613
Autor:
S D, Silberstein, D C, McCrory
Publikováno v:
Cephalalgia. 20:854-864
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::021ec143471f5f223b2bf0b95d4f7b38
https://doi.org/10.1046/j.1468-2982.2000.00149.x
https://doi.org/10.1046/j.1468-2982.2000.00149.x
Publikováno v:
Cephalalgia. 20:787-803
Cluster headache is a stereotypic, primary headache disorder that is marked by repeated short-lasting attacks of severe, unilateral head pain and associated autonomic symptoms. Cluster headache is probably due to an abnormality in the circadian hypot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6590b47fafe1edb180218389d1fc2ad
https://doi.org/10.1046/j.1468-2982.2000.00118.x
https://doi.org/10.1046/j.1468-2982.2000.00118.x
Autor:
S D, Silberstein
Publikováno v:
Journal of Women's Health & Gender-Based Medicine. 8:919-931
Migraine in women is influenced by hormonal changes throughout the life cycle: menarche, menstruation, oral contraceptive use, pregnancy, menopause, and hormonal replacement therapy (HRT). Based on clinical experience, the frequency of menstrual migr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d836e0d2ace284db0a8a0d36129ab846
https://doi.org/10.1089/jwh.1.1999.8.919
https://doi.org/10.1089/jwh.1.1999.8.919
Autor:
S D, Silberstein
Publikováno v:
Cephalalgia. 18:421-435
Methysergide is a semisynthetic ergot alkaloid ergometrine derivative, introduced in pharmacotherapy for migraine prophylaxis as a specific serotonin (5HT) receptor antagonist. Methysergide is not just a 5HT2 antagonist, it is also a 5HT1 agonist. Op
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a105804c4ab898e43127332191886306
https://doi.org/10.1046/j.1468-2982.1998.1807421.x
https://doi.org/10.1046/j.1468-2982.1998.1807421.x
Autor:
W B, Young, S D, Silberstein
Publikováno v:
Journal of neurosurgical sciences. 56(4)
Occipital nerve stimulation may be effective for primary headache disorders. Four studies, including two double-blind show, stimulation-controlled studies that were performed for chronic migraine showed evidence of benefit. A separate study suggested
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::567abf46a65ab95e357322fe320df3ef
https://pubmed.ncbi.nlm.nih.gov/23111291
https://pubmed.ncbi.nlm.nih.gov/23111291
To provide updated evidence-based recommendations for the preventive treatment of migraine headache. The clinical question addressed was: What pharmacologic therapies are proven effective for migraine prevention?The authors analyzed published studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7efd6522dadfe5544abe38c55797a3bf
https://europepmc.org/articles/PMC3335452/
https://europepmc.org/articles/PMC3335452/
